SCHEMBL4876859

SCHEMBL4876859

Cc1cc(C(=O)O)c(O)c(C(=O)O)c1C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LDHA P00338 3/20 0.48
LDHB P07195 3/20 0.48
HMGB1 P09429 1/20 0.48
CXCL12 P48061 1/20 0.48
ALDH1A1 P00352 2/20 0.44
CYP3A4 P08684 3/20 0.44
KDM4E B2RXH2 2/20 0.44
HPGD P15428 2/20 0.44
HSD17B10 Q99714 2/20 0.44
ACHE P22303 1/20 0.44
MAPT P10636 2/20 0.42
KMT2A Q03164 2/20 0.42
CYP2C9 P11712 1/20 0.42
GAA P10253 2/20 0.41
GRM1 Q13255 2/20 0.40
AKR1C4 P17516 2/20 0.39
AKR1C3 P42330 2/20 0.39
AKR1C2 P52895 2/20 0.39
AKR1C1 Q04828 2/20 0.39
CSNK2A1 P68400 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11561454 0.88 HMGB1 (0.46) LDHALDHBHMGB1CXCL12ALDH1A1
SCHEMBL27777852 0.85 HMGB1 (0.55) LDHALDHBHMGB1CXCL12ALDH1A1
SCHEMBL10785106 0.83 LDHA (0.48) LDHALDHBHMGB1CXCL12ALDH1A1
SCHEMBL29031971 0.83 CYP3A4 (0.50) LDHALDHBHMGB1CXCL12ALDH1A1
SCHEMBL4641265 0.83 LDHA (0.48) LDHALDHBHMGB1CXCL12ALDH1A1
SCHEMBL14989265 0.83 KDM4E (0.44) LDHALDHBHMGB1CXCL12ALDH1A1
SCHEMBL6904405 0.83 KDM4E (0.45) LDHALDHBHMGB1CXCL12ALDH1A1
SCHEMBL8830205 0.83 LDHA (0.52) LDHALDHBHMGB1CXCL12ALDH1A1
SCHEMBL31315038 0.83 HMGB1 (0.52) LDHALDHBHMGB1CXCL12ALDH1A1
SCHEMBL8830153 0.83 HMGB1 (0.52) LDHALDHBHMGB1CXCL12ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0132717-B1 HEAT-SENSITIVE RECORD MATERIAL KANZAKI PAPER MANUFACTURING COMPANY LIMITED (JP) 1987-04-22 EP claimed
US-20080132689-A1 Complexing using an ortho carboxy acetal; biodrug delivery ROCHE MADISON INC 2008-06-05 US disclosed
US-7348453-B2 Labile linkage for compound delivery to a cell MIRUS BIO CORPORATION (US) 2008-03-25 US disclosed
WO-2005026253-A2 LABILE LINKAGE FOR COMPOUND DELIVERY TO A CELL MIRUS BIO CORPORATION (US) 2005-03-24 WO disclosed
US-20050054604-A1 Labile linkage for compound delivery to a cell ROCHE MADISON INC. 2005-03-10 US disclosed
US-20030144458-A1 Novel amphiphilic polymeric materials UNIVERSITY OF MASSACHUSETTS, A MASSACHUSETTS CORPORATION 2003-07-31 US disclosed
US-6521736-B2 Can be used in development of physiologically stable, non-leaking, non-immunogenic, efficacious and safe targetable drug delivery systems e.g., for delivery of anti-HIV or anticancer drugs UNIVERSITY OF MASSACHUSETTS 2003-02-18 US disclosed
US-20020099164-A1 Novel amphiphilic polymeric materials UNIVERSITY OF MASSACHUSETTS 2002-07-25 US disclosed
EP-0583609-A1 Multiply-branched aliphatic-aromatic polyether esters and their preparation EASTMAN KODAK COMPANY (US) 1994-02-23 EP disclosed
US-5225522-A Multiply-branched aliphatic-aromatic polyesters and method for preparing multiply-branched aliphatic-aromatic polyesters EASTMAN KODAK COMPANY (US) 1993-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050054604-A1 Labile linkage for compound delivery to a cell AADAC, PAICS, FURIN LDHA 1567/4885LDHB 1332/4885HMGB1 885/4885
US-20080132689-A1 Complexing using an ortho carboxy acetal; biodrug delivery CEL, PAICS, OGA LDHA 2656/4885LDHB 2273/4885HMGB1 1282/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.